Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.83 USD | +10.06% | +12.65% | -72.66% |
Apr. 18 | Genelux Insider Sold Shares Worth $256,227, According to a Recent SEC Filing | MT |
Apr. 02 | HC Wainwright Cuts Price Target on Genelux to $32 From $35, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.66% | 101M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- GNLX Stock
- News Genelux Corporation
- Genelux, TVAX Biomedical Secure US Patent on Cancer Combination Therapy